Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Open Label Phase 1/2 Trial of Tisotumab Vedotin in Japanese Subjects With Advanced Solid Malignancies

NCT03913741 is registered in ClinicalTrials.gov with Genmab as lead sponsor.

NCT NCT03913741
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT03913741 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Open Label Phase 1/2 Trial of Tisotumab Vedotin in Japanese Subjects With Advanced Solid Malignancies
Lead sponsor
Genmab
Phase
Phase 1/2
Overall status
Completed
Start date
February 27, 2019
Completion date
October 30, 2021
Enrollment
23 (actual)
Sites
8

Conditions

As the registry lists them; a condition with its own page is linked.

solid tumor